from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1013/pks16

LFCtreatmentdescriptionclass of inhibitor

-1.187

Amikacinug/mL Amikacintranslation

-0.669

Cap5-10ug/mL Capreomycintranslation

-0.608

Rox10-50 ug/mL Roxithromycintranslation

-1.267

SM2-5 ug/mL Streptomycintranslation

-1.580

Tet5-10 ug/mL Tetracyclinetranslation

-0.809

Rif0.2-5ug/mL Rifampicintranscription

-0.027

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.139

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.227

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.419

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.634

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.302

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.645

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.000

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.256

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.714

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.370

Nigericin50 uM Nigericinrespiration

-0.985

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

0.727

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.896

menadione6-10 ug/mL Menadionerespiration

-0.757

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.316

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.219

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.836

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.678

NRP_1Non-replicating persistence stage 1dosRassociated

-0.273

Amp0.2mg/mL AmpicillincellWall

0.260

Cephalexin20-100 ug/mL CephalexincellWall

1.652

Cerulenin0.32-5 ug/mL CerulenincellWall

0.252

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.376

EMB10-20 ug/mL EthambutolcellWall

1.828

Eta12-40 ug/mL EthionamidecellWall

1.838

INH0.2-0.4 ug/mL IsoniazidcellWall

2.568

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.440

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.392

BZA0.12 mg/mL BenzamidearomaticAmides

-0.269

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.108

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.073

H2O24 mM hydrogen peroxideDNAdamaging

0.384

Levo10 ug/mL LevofloxacinDNAdamaging

0.264

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.013

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.112

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.502

Antimycin12.5-50 ug/mL Antimycin A?

0.938

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.811

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.502

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.098

PA8240.2-2 ug/mL PA-824?

-1.408

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-1.190

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.530

Verapamil50 uM Verapamil?

0.365

mercaptoethanol2 mM 2-Mercaptoethanol?

0.863

methoxatin10-20 ug/mL Methoxatin?